✦ LIBER ✦

Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in Korea

✍ Scribed by Chul Sik Kim; Jae Hyun Nam; Ji Sun Nam; Jong Suk Park; Eun Seok Kang; Chul Woo Ahn; Bong Soo Cha; Sung Kil Lim; Kyung Rae Kim; Hyun Chul Lee; Kap Bum Huh

Book ID: 119325393
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 156 KB
Volume: 55
Category: Article
ISSN: 1532-8600
DOI: 10.1016/j.metabol.2006.04.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thyroid autoantibodies in Thai type 1 di

Thyroid autoantibodies in Thai type 1 diabetic patients: clinical significance and their relationship with glutamic acid decarboxylase antibodies

✍ Chatchalit Rattarasarn; Manuel Aguilar Diosdado; Jose Ortego; Rattana Leelawatta 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Islet cell antibodies and glutamic acid

Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1[frac12] diabetes in patients presenting with type 2 diabetes

✍ Rattan Juneja; Irl B. Hirsch; Ramachandra G. Naik; Barbara M. Brooks-Worrell; Ca 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Correlation between glutamic acid decarb

Correlation between glutamic acid decarboxylase 65 antibody, IA-2 antibody and HLA-DR genotypes in Japanese patients with type 1 diabetes

✍ Taro Maruyama; Akira Kasuga; Shinya Nakamoto; Akira Shimada; Kohichi Matsubara; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Prevalence and clinical characteristics

Prevalence and clinical characteristics of diabetic peripheral neuropathy in hospital patients with Type 2 diabetes in Korea

✍ J. C. Won; H. S. Kwon; C. H. Kim; J. H. Lee; T. S. Park; K. S. Ko; B. Y. Cha 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB

Clinical significance and time course of

Clinical significance and time course of antibodies to glutamic acid decarboxylase in Japanese children with type I (insulin-dependent) diabetes mellitus

✍ S Sugihara; S Konda; K Wataki; Y Kobayashi; A Murata; S Miyamoto; H Kubo; A Yama 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

Elimination of islet cell antibodies and

Elimination of islet cell antibodies and glutamic acid decarboxylase antibodies II in a patient with newly diagnosed insulin-dependent diabetes mellitus

✍ W. O. Richter; M. G. Donner; P. Schwandt 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Islet cell antibodies and glutamic acid decarboxylase II (GAD II) antibodies have been discussed in the autoimmune pathogenesis of insulin-dependent diabetes mellitus (IDDM). Hence, immunosuppressants, intravenous immunoglobulins, and plasmapheresis have been used in an effort to modulate autoimmune